August 20, 2024

Analysis of the long-term prognosis of transjugular intrahepatic portosystemic shunt treatment for esophagogastric variceal hemorrhage concomitant with sarcopenia in cirrhotic patients.

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To explore whether transjugular intrahepatic portosystemic shunt (TIPS) can improve the prognosis of esophagogastric variceal bleeding (EGVB) combined with sarcopenia in cirrhotic patients.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Wang et al. (Tue,) studied this question.

synapsesocial.com/papers/68e5bb23b6db643587552f89 https://doi.org/https://doi.org/10.3760/cma.j.cn501113-20240414-00203

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficacy of transjugular intrahepatic portosystemic shunts in treating cirrhotic esophageal-gastric variceal bleeding2024 · 3 citations
2Outcomes after TIPS in patients with cirrhosis and sarcopenia: A systematic review and meta-analysis.2026
3Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus2024 · 2 citations
4Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt2024 · 8 citations
5Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis2024 · 4 citations

Preguntar a la IA

Me gusta

Guardar